Vitamin K is the blood-clotting vitamin. The mechanism of action of vi
tamin K is discussed in terms of a new carbanion model that mimics the
proton abstraction from the gamma position of protein-bound glutamate
. This is the essential step leading to carboxylation and activation o
f the blood-clotting proteins. The model comprises an oxygenation that
is coupled to carbon-carbon bond formation, as is the oxygenation of
vitamin K hydroquinone to vitamin K oxide. The model hypothesis is als
o supported by the mechanism of inhibition of the carboxylase by HCN,
which acts as an acid-base inhibitor rather than a metal-complexing in
hibitor. The new model postulates a dioxetane intermediate that explai
ns the presence of a second atom of O-18 (from O-18(2)) incorporated i
nto vitamin K oxide in the course of the enzymatic carboxylation. Fina
lly, the chemistry developed here has been used to define the active s
ite of vitamin K hydroquinone as the carbon-carbon bond adjacent to th
e methyl group.